Mahendra Rao is internationally known for his research involving human embryonic stem cells and other somatic stem cells. Mahendra Rao received his PhD in Developmental Neurobiology from the California Institute of Technology. Rao led the Stem cell and Regnerative Medicine division at LiFE Technologies and then served as the Director of the NIH Center of Regenerative Medicine. He co-founded Q Therapeutics, a stem-cell research firm and serves on USDA Cellular Tissue and Gene Therapies advisory committee and more. Dr. Rao is currently the CEO of Implant Therapeutics and continues his consulting work in the field of regenerative medicine and stem cell therapies.